
![]() |
Leroy F. Liu Professor and Chairman Department of Pharmacology Robert Wood Johnson Medical School B.S., National Taiwan University, 1971 Ph.D., University of California, Berkeley, 1977 Office: RWJMS/Piscataway R436 |
Tumorigenesis, topoisomerases,
telomere regulation and senescence, DNA damage and repair. |
Research Description: Our main research interest is in the areas of cancer biology and cancer pharmacology. The following specific research projects are currently being conducted in this laboratory: |
| 1. Studies on topoisomerase I-mediated DNA damage. Top I has been firmly established as a highly effective new molecular target for antitumor drugs such as camptothecins (CPTs) (e.g. irinotecan and topotecan). CPTs kill tumor cells by trapping a key covalent Top I-DNA reaction intermediate, the reversible cleavable complex. In addition to CPTs and other Top I-directed drugs, DNA structural modifications (e.g. benzo[a]pyrene-DNA adducts, UV adducts, oxidative modifications and AraC-substituted DNA) have been shown to cause trapping of Top I cleavable complexes. Despite the importance of Top I cleavable complexes as a new type of cellular lesion, our current understanding of repair/processing of Top I cleavable complexes is still quite limited. We have identified two novel molecular events downstream of the Top I cleavable complex, ubiquitin/26S proteasome-mediated degradation of Top I (Top I down-regulation) and SUMO-1 (small ubiquitin-related modifier) conjugation to Top I. The roles of these two novel pathways in the repair/processing of Top I cleavable complexes are being investigated. |
| 2. Studies on topoisomerase II-mediated DNA damage. Top II-mediated DNA damage has been recognized as an important form of DNA lesion. Top II performs its function through its delicate act of breaking/rejoining DNA strands to resolve topological problems arising during DNA replication, transcription, and chromosome condensation and segregation. Because of its delicate act on DNA, Top II is highly vulnerable to xenobiotics (e.g. VP-16 and doxorubicin), DNA structural modifications (e.g. abasic sites) and cellular stresses (e.g. pH and thiol stresses). These insults abort the Top II reaction by trapping the reversible covalent Top II-DNA intermediate, termed the cleavable complexes. We are currently investigating the role of Top II-mediated DNA damage in the following three areas; (1) the role of transcription elongation and the ubiquitin/26S proteasome pathway in repair/processing of Top II cleavage complexes, (2) the role of Top II isozymes in ischemic acidosis and the nuclear-mitochondial signaling pathway leading to acidotic apoptosis, and (3) the role of Top II isozymes in tumorigenesis. |
| 3. Studies on telomere-initiated senescence and apoptosis. Telomeres have been suggested to play a role in cellular senescence/aging and tumorigenesis. Telomere de-protection is known to trigger DNA damage/apoptotic signaling and cellular senescence. We have recently demonstrated that introduction of telomeric G-quartet DNA into cells triggers DNA damage/apoptotic signaling and cellular senescence. Moreover, overexpression of TRF-2 suppresses the effect of G-quartet DNA, suggesting that G-quartet DNA may play a role in telomere regulation and cellular senescence. We are currently testing the hypothesis that the regulated inter-conversion between the G-quartet DNA and the single-stranded G-tail DNA plays a major regulatory role in telomere maintenance and cellular senescence/cell death. |